Telehealth Ready: Performance of the Amiko Respiro Sense connected technology with Merxin DPIs

Philippe Rogueda¹, Martijn Grinovero², Luca Ponti², Graham Purkins¹ & Oliver Croad¹

¹Merxin Ltd, King’s Lynn Innovation Centre, Innovation Way, King’s Lynn, PE30 5BY, UK

²Amiko Digital Health Limited, Salisbury House 31 Finsbury Circus, London, EC2M 5QQ, UK

Summary

Data presented in this abstract demonstrate the use of Amiko Respiro Sense technology in the form of an add-on attachment to the blister and capsule based Merxin DPIs, MRX001 and MRX003.  The technology can capture clinical and real-world adherence data used to steer treatment regimens and improve patient inhaler technique. Key device usage metrics such as peak inspiratory flow, inhalatory volume, inhalation time and the whole flow profile were collected and assessed using breath simulation apparatus and compared to estimations of these parameters provided by the Respiro Sense technology. Accuracy values were calculated to be around 90% or above for all these respiratory parameters, indicating that the combination of Respiro Sense with the Merxin devices can be used to accurately estimate key measures of inhaler usage and lung health.